Drugs / IFN-a-2a
last change Nov 2018 re-read 2 minutes ago

IFN-a-2a

Protein / enzyme biologic

Developed for
chronic hepatitis B virus infection

Trials 0

Also used as a comparator or background therapy in 1 trial
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 1/2 NCT02615639 Comparator Nov 2015 → Nov 2018 chronic hepatitis B virus infection Third Affiliated Hospital, Sun Yat-Sen University Unknown No outcome recorded

Evidence & citations 3 cited values

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as IFN-a-2a ClinicalTrials.gov intervention name — accepted as the source's own label NCT02615639
Modality Protein / enzyme biologic “interferon(IFN)-a-2a” NCT02615639
Route Subcutaneous “IFN-a-2a 180ug subcutaneous injection every week” NCT02615639